The research status of immune checkpoint blockade by anti-CTLA4 and anti-PD1/PD-l1 antibodies in tumor immunotherapy in China: A bibliometrics study

PURPOSE: Using bibliometrics, we analyzed the research status of immune checkpoint blockade (ICB, a popular tumor immunotherapy method represented by antibodies targeted CTLA-4 and PD-1/PD-L1) in tumor immunotherapy in China during the past 2 decades. METHODS: Articles in Science Citation Index Expa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xiaoqin, He, Liangmei, Mao, Kaiyun, Chen, Daming, Jiang, Hongbo, Liu, Zhiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
3600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908611/
https://www.ncbi.nlm.nih.gov/pubmed/29642147
http://dx.doi.org/10.1097/MD.0000000000010276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908611/
https://www.ncbi.nlm.nih.gov/pubmed/29642147
http://dx.doi.org/10.1097/MD.0000000000010276

Ejemplares similares